Advertisement

Phospholipases: An Overview

  • Ahmed AloulouEmail author
  • Yassine Ben Ali
  • Sofiane Bezzine
  • Youssef Gargouri
  • Michael H. Gelb
Protocol
Part of the Methods in Molecular Biology book series (MIMB, volume 861)

Abstract

Phospholipids are present in all living organisms. They are a major component of all biological membranes, along with glycolipids and cholesterol. Enzymes aimed at cleaving the various bonds in phospholipids, namely phospholipases, are consequently widespread in nature, playing very diverse roles from aggression in snake venom to signal transduction, lipid mediators production, and digestion in humans. Although all phospholipases target phospholipids as substrates, they vary in the site of action on the phospholipids molecules, physiological function, mode of action, and their regulation. Significant studies on phospholipases characterization, physiological role, and industrial potential have been conducted worldwide. Some of them have been directed for biotechnological advances, such as gene discovery and functional enhancement by protein engineering. Others reported phospholipases as virulence factors and major causes of pathophysiological effects. In this introductory chapter, we provide brief details of different phospholipases.

Key words

Phospholipases Classification Physiological function Industrial application 

References

  1. 1.
    Exton JH (1997) New developments in phospholipase D. J Biol Chem 272:15579–15582PubMedGoogle Scholar
  2. 2.
    Farn JL, Strugnell RA, Hoyne PA et al (2001) Molecular characterization of a secreted enzyme with phospholipase B activity from Moraxella bovis. J Bacteriol 183:6717–6720PubMedGoogle Scholar
  3. 3.
    Singer WD, Brown HA, Sternweis PC (1997) Regulation of eukaryotic phosphatidylinositol-specific phospholipase C and phospholipase D. Annu Rev Biochem 66:475–509PubMedGoogle Scholar
  4. 4.
    Bornscheuer UT, Kazlauskas RJ (2004) Catalytic promiscuity in biocatalysis: using old enzymes to form new bonds and follow new pathways. Angew Chem Int Ed Engl 43:6032–6040PubMedGoogle Scholar
  5. 5.
    De Maria L, Vind J, Oxenboll KM et al (2007) Phospholipases and their industrial applications. Appl Microbiol Biotechnol 74:290–300PubMedGoogle Scholar
  6. 6.
    Kazlauskas RJ (2005) Enhancing catalytic promiscuity for biocatalysis. Curr Opin Chem Biol 9:195–201PubMedGoogle Scholar
  7. 7.
    Aoki J, Nagai Y, Hosono H et al (2002) Structure and function of phosphatidylserine-specific phospholipase A1. Biochim Biophys Acta 1582:26–32PubMedGoogle Scholar
  8. 8.
    Sato T, Aoki J, Nagai Y et al (1997) Serine phospholipid-specific phospholipase A that is secreted from activated platelets. A new member of the lipase family. J Biol Chem 272:2192–2198PubMedGoogle Scholar
  9. 9.
    King TP, Kochoumian L, Joslyn A (1984) Wasp venom proteins: phospholipase A1 and B. Arch Biochem Biophys 230:1–12PubMedGoogle Scholar
  10. 10.
    Hiramatsu T, Sonoda H, Takanezawa Y et al (2003) Biochemical and molecular characterization of two phosphatidic acid-selective phospholipase A1s, mPA-PLA1alpha and mPA-PLA1beta. J Biol Chem 278:49438–49447PubMedGoogle Scholar
  11. 11.
    Carriere F, Withers-Martinez C, van Tilbeurgh H et al (1998) Structural basis for the substrate selectivity of pancreatic lipases and some related proteins. Biochim Biophys Acta 1376:417–432PubMedGoogle Scholar
  12. 12.
    Simons JW, Gotz F, Egmond MR et al (1998) Biochemical properties of staphylococcal (phospho)lipases. Chem Phys Lipids 93:27–37PubMedGoogle Scholar
  13. 13.
    Tiesinga JJ, van Pouderoyen G, Nardini M et al (2007) Structural basis of phospholipase activity of Staphylococcus hyicus lipase. J Mol Biol 371:447–456PubMedGoogle Scholar
  14. 14.
    Heikinheimo P, Goldman A, Jeffries C et al (1999) Of barn owls and bankers: a lush variety of alpha/beta hydrolases. Structure 7:R141–R146PubMedGoogle Scholar
  15. 15.
    Simons JW, Boots JW, Kats MP et al (1997) Dissecting the catalytic mechanism of staphylococcal lipases using carbamate substrates: chain length selectivity, interfacial activation, and cofactor dependence. Biochemistry 36:14539–14550PubMedGoogle Scholar
  16. 16.
    Dekker N (2000) Outer-membrane phospholipase A: known structure, unknown biological function. Mol Microbiol 35:711–717PubMedGoogle Scholar
  17. 17.
    Kingma RL, Fragiathaki M, Snijder HJ et al (2000) Unusual catalytic triad of Escherichia coli outer membrane phospholipase A. Biochemistry 39:10017–10022PubMedGoogle Scholar
  18. 18.
    Snijder HJ, Dijkstra BW (2000) Bacterial phospholipase A: structure and function of an integral membrane phospholipase. Biochim Biophys Acta 1488:91–101PubMedGoogle Scholar
  19. 19.
    Schmiel DH, Wagar E, Karamanou L et al (1998) Phospholipase A of Yersinia enterocolitica contributes to pathogenesis in a mouse model. Infect Immun 66:3941–3951PubMedGoogle Scholar
  20. 20.
    Murakami M, Taketomi Y, Miki Y et al (2011) Recent progress in phospholipase A(2) research: From cells to animals to humans. Prog Lipid Res 50:152–192PubMedGoogle Scholar
  21. 21.
    Schaloske RH, Dennis EA (2006) The phospholipase A2 superfamily and its group numbering system. Biochim Biophys Acta 1761:1246–1259PubMedGoogle Scholar
  22. 22.
    Valentin E, Singer AG, Ghomashchi F et al (2000) Cloning and recombinant expression of human group IIF-secreted phospholipase A(2). Biochem Biophys Res Commun 279:223–228PubMedGoogle Scholar
  23. 23.
    Lee HY, Bahn SC, Shin JS et al (2005) Multiple forms of secretory phospholipase A2 in plants. Prog Lipid Res 44:52–67PubMedGoogle Scholar
  24. 24.
    Ryu Y, Oh Y, Yoon J et al (2003) Molecular characterization of a gene encoding the Drosophila melanogaster phospholipase A2. Biochim Biophys Acta 1628:206–210PubMedGoogle Scholar
  25. 25.
    McIntosh JM, Ghomashchi F, Gelb MH et al (1995) Conodipine-M, a novel phospholipase A2 isolated from the venom of the marine snail Conus magus. J Biol Chem 270:3518–3526PubMedGoogle Scholar
  26. 26.
    Kini RM (2003) Excitement ahead: structure, function and mechanism of snake venom phospholipase A2 enzymes. Toxicon 42:827–840PubMedGoogle Scholar
  27. 27.
    Valentin E, Lambeau G (2000) Increasing molecular diversity of secreted phospholipases A(2) and their receptors and binding proteins. Biochim Biophys Acta 1488:59–70PubMedGoogle Scholar
  28. 28.
    Canaan S, Zadori Z, Ghomashchi F et al (2004) Interfacial enzymology of parvovirus phospholipases A2. J Biol Chem 279:14502–14508PubMedGoogle Scholar
  29. 29.
    Soragni E, Bolchi A, Balestrini R et al (2001) A nutrient-regulated, dual localization phospholipase A(2) in the symbiotic fungus Tuber borchii. EMBO J 20:5079–5090PubMedGoogle Scholar
  30. 30.
    Sugiyama M, Ohtani K, Izuhara M et al (2002) A novel prokaryotic phospholipase A2. Characterization, gene cloning, and solution structure. J Biol Chem 277:20051–20058PubMedGoogle Scholar
  31. 31.
    Matoba Y, Katsube Y, Sugiyama M (2002) The crystal structure of prokaryotic phospholipase A2. J Biol Chem 277:20059–20069PubMedGoogle Scholar
  32. 32.
    Valentin E, Ghomashchi F, Gelb MH et al (2000) Novel human secreted phospholi-pase A(2) with homology to the group III bee venom enzyme. J Biol Chem 275:7492–7496PubMedGoogle Scholar
  33. 33.
    Singer AG, Ghomashchi F, Le Calvez C et al (2002) Interfacial kinetic and binding properties of the complete set of human and mouse groups I, II, V, X, and XII secreted phospholipases A2. J Biol Chem 277:48535–48549PubMedGoogle Scholar
  34. 34.
    Ni Z, Okeley NM, Smart BP et al (2006) Intracellular actions of group IIA secreted phospholipase A2 and group IVA cytosolic phospholipase A2 contribute to arachidonic acid release and prostaglandin production in rat gastric mucosal cells and transfected human embryonic kidney cells. J Biol Chem 281:16245–16255PubMedGoogle Scholar
  35. 35.
    Mounier CM, Ghomashchi F, Lindsay MR et al (2004) Arachidonic acid release from mammalian cells transfected with human groups IIA and X secreted phospholipase A(2) occurs predominantly during the secretory process and with the involvement of cytosolic phospholipase A(2)-alpha. J Biol Chem 279:25024–25038PubMedGoogle Scholar
  36. 36.
    Bezzine S, Koduri RS, Valentin E et al (2000) Exogenously added human group X secreted phospholipase A(2) but not the group IB, IIA, and V enzymes efficiently release arachidonic acid from adherent mammalian cells. J Biol Chem 275:3179–3191PubMedGoogle Scholar
  37. 37.
    Koduri RS, Gronroos JO, Laine VJ et al (2002) Bactericidal properties of human and murine groups I, II, V, X, and XII secreted phospholipases A(2). J Biol Chem 277:5849–5857PubMedGoogle Scholar
  38. 38.
    Webb NR (2005) Secretory phospholipase A2 enzymes in atherogenesis. Curr Opin Lipidol 16:341–344PubMedGoogle Scholar
  39. 39.
    Kudo I, Murakami M, Hara S et al (1993) Mammalian non-pancreatic phospholipases A2. Biochim Biophys Acta 1170:217–231PubMedGoogle Scholar
  40. 40.
    Akiba S, Hatazawa R, Ono K et al (2001) Secretory phospholipase A2 mediates cooperative prostaglandin generation by growth factor and cytokine independently of preceding cytosolic phospholipase A2 expression in rat gastric epithelial cells. J Biol Chem 276:21854–21862PubMedGoogle Scholar
  41. 41.
    Kim KP, Rafter JD, Bittova L et al (2001) Mechanism of human group V phospholipase A2 (PLA2)-induced leukotriene biosynthesis in human neutrophils. A potential role of heparan sulfate binding in PLA2 internalization and degradation. J Biol Chem 276:11126–11134PubMedGoogle Scholar
  42. 42.
    Snitko Y, Yoon ET, Cho W (1997) High specificity of human secretory class II phospholipase A2 for phosphatidic acid. Biochem J 321:737–741PubMedGoogle Scholar
  43. 43.
    Fourcade O, Simon MF, Viode C et al (1995) Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells. Cell 80:919–927PubMedGoogle Scholar
  44. 44.
    Atsumi G, Murakami M, Tajima M et al (1997) The perturbed membrane of cells undergoing apoptosis is susceptible to type II secretory phospholipase A2 to liberate arachidonic acid. Biochim Biophys Acta 1349:43–54PubMedGoogle Scholar
  45. 45.
    Nevalainen TJ, Graham GG, Scott KF (2008) Antibacterial actions of secreted phospholipases A2. Review. Biochim Biophys Acta 1781:1–9PubMedGoogle Scholar
  46. 46.
    Koprivnjak T, Peschel A, Gelb MH et al (2002) Role of charge properties of bacterial envelope in bactericidal action of human group IIA phospholipase A2 against Staphylococcus aureus. J Biol Chem 277:47636–47644PubMedGoogle Scholar
  47. 47.
    Chen J, Shao C, Lazar V et al (1997) Localization of group IIc low molecular weight phospholipase A2 mRNA to meiotic cells in the mouse. J Cell Biochem 64:369–375PubMedGoogle Scholar
  48. 48.
    Tischfield JA, Xia YR, Shih DM et al (1996) Low-molecular-weight, calcium-dependent phospholipase A2 genes are linked and map to homologous chromosome regions in mouse and human. Genomics 32:328–333PubMedGoogle Scholar
  49. 49.
    Valentin E, Koduri RS, Scimeca JC et al (1999) Cloning and recombinant expression of a novel mouse-secreted phospholipase A2. J Biol Chem 274:19152–19160PubMedGoogle Scholar
  50. 50.
    Ishizaki J, Suzuki N, Higashino K et al (1999) Cloning and characterization of novel mouse and human secretory phospholipase A(2)s. J Biol Chem 274:24973–24979PubMedGoogle Scholar
  51. 51.
    Chen J, Engle SJ, Seilhamer JJ et al (1994) Cloning and recombinant expression of a novel human low molecular weight Ca(2+)-dependent phospholipase A2. J Biol Chem 269:2365–2368PubMedGoogle Scholar
  52. 52.
    Murakami M, Koduri RS, Enomoto A et al (2001) Distinct arachidonate-releasing functions of mammalian secreted phospholipase A2s in human embryonic kidney 293 and rat mastocytoma RBL-2H3 cells through heparan sulfate shuttling and external plasma membrane mechanisms. J Biol Chem 276:10083–10096PubMedGoogle Scholar
  53. 53.
    Kim YM, Lee YM, Kim HS et al (2002) TNF-related activation-induced cytokine (TRANCE) induces angiogenesis through the activation of Src and phospholipase C (PLC) in human endothelial cells. J Biol Chem 277:6799–6805PubMedGoogle Scholar
  54. 54.
    Balboa MA, Shirai Y, Gaietta G et al (2003) Localization of group V phospholipase A2 in caveolin-enriched granules in activated P388D1 macrophage-like cells. J Biol Chem 278:48059–48065PubMedGoogle Scholar
  55. 55.
    Wijewickrama GT, Kim JH, Kim YJ et al (2006) Systematic evaluation of transcellular activities of secretory phospholipases A2. High activity of group V phospholipases A2 to induce eicosanoid biosynthesis in neighboring inflammatory cells. J Biol Chem 281:10935–10944PubMedGoogle Scholar
  56. 56.
    Munoz NM, Meliton AY, Lambertino A et al (2006) Transcellular secretion of group V phospholipase A2 from epithelium induces beta 2-integrin-mediated adhesion and synthesis of leukotriene C4 in eosinophils. J Immunol 177:574–582PubMedGoogle Scholar
  57. 57.
    Ohtsuki M, Taketomi Y, Arata S et al (2006) Transgenic expression of group V, but not group X, secreted phospholipase A2 in mice leads to neonatal lethality because of lung dysfunction. J Biol Chem 281:36420–36433PubMedGoogle Scholar
  58. 58.
    Wooton-Kee CR, Boyanovsky BB, Nasser MS et al (2004) Group V sPLA2 hydrolysis of low-density lipoprotein results in spontaneous particle aggregation and promotes macrophage foam cell formation. Arterioscler Thromb Vasc Biol 24:762–767PubMedGoogle Scholar
  59. 59.
    Ishimoto Y, Yamada K, Yamamoto S et al (2003) Group V and X secretory phospholipase A(2)s-induced modification of high-density lipoprotein linked to the reduction of its antiatherogenic functions. Biochim Biophys Acta 1642:129–138PubMedGoogle Scholar
  60. 60.
    Gesquiere L, Cho W, Subbaiah PV (2002) Role of group IIa and group V secretory phospholipases A(2) in the metabolism of lipoproteins. Substrate specificities of the enzymes and the regulation of their activities by sphingomyelin. Biochemistry 41:4911–4920PubMedGoogle Scholar
  61. 61.
    Mitsuishi M, Masuda S, Kudo I et al (2007) Human group III phospholipase A2 suppresses adenovirus infection into host cells. Evidence that group III, V and X phospholipase A2s act on distinct cellular phospholipid molecular species. Biochim Biophys Acta 1771:1389–1396PubMedGoogle Scholar
  62. 62.
    Boilard E, Lai Y, Larabee K et al (2010) A novel anti-inflammatory role for secretory phospholipase A2 in immune complex-mediated arthritis. EMBO Mol Med 2:172–187PubMedGoogle Scholar
  63. 63.
    Balestrieri B, Hsu VW, Gilbert H et al (2006) Group V secretory phospholipase A2 translocates to the phagosome after zymosan stimulation of mouse peritoneal macrophages and regulates phagocytosis. J Biol Chem 281:6691–6698PubMedGoogle Scholar
  64. 64.
    Bradley JD, Dmitrienko AA, Kivitz AJ et al (2005) A randomized, double-blinded, placebo-controlled clinical trial of LY333013, a selective inhibitor of group II secretory phospholipase A2, in the treatment of rheumatoid arthritis. J Rheumatol 32:417–423PubMedGoogle Scholar
  65. 65.
    Rosengren B, Peilot H, Umaerus M et al (2006) Secretory phospholipase A2 group V: lesion distribution, activation by arterial proteoglycans, and induction in aorta by a Western diet. Arterioscler Thromb Vasc Biol 26:1579–1585PubMedGoogle Scholar
  66. 66.
    Boyanovsky BB, van der Westhuyzen DR, Webb NR (2005) Group V secretory phospholipase A2-modified low density lipoprotein promotes foam cell formation by a SR-A- and CD36-independent process that involves cellular proteoglycans. J Biol Chem 280:32746–32752PubMedGoogle Scholar
  67. 67.
    Bostrom MA, Boyanovsky BB, Jordan CT et al (2007) Group v secretory phospholipase A2 promotes atherosclerosis: evidence from genetically altered mice. Arterioscler Thromb Vasc Biol 27:600–606PubMedGoogle Scholar
  68. 68.
    Masuda S, Murakami M, Mitsuishi M et al (2005) Expression of secretory phospholipase A2 enzymes in lungs of humans with pneumonia and their potential prostaglandin-synthetic function in human lung-derived cells. Biochem J 387:27–38PubMedGoogle Scholar
  69. 69.
    Masuda S, Murakami M, Ishikawa Y et al (2005) Diverse cellular localizations of secretory phospholipase A2 enzymes in several human tissues. Biochim Biophys Acta 1736:200–210PubMedGoogle Scholar
  70. 70.
    Balestrieri B, Maekawa A, Xing W et al (2009) Group V secretory phospholipase A2 modulates phagosome maturation and regulates the innate immune response against Candida albicans. J Immunol 182:4891–4898PubMedGoogle Scholar
  71. 71.
    Morioka Y, Saiga A, Yokota Y et al (2000) Mouse group X secretory phospholipase A2 induces a potent release of arachidonic acid from spleen cells and acts as a ligand for the phospholipase A2 receptor. Arch Biochem Biophys 381:31–42PubMedGoogle Scholar
  72. 72.
    Mounier CM, Wendum D, Greenspan E et al (2008) Distinct expression pattern of the full set of secreted phospholipases A2 in human colorectal adenocarcinomas: sPLA2-III as a biomarker candidate. Br J Cancer 98:587–595PubMedGoogle Scholar
  73. 73.
    Eerola LI, Surrel F, Nevalainen TJ et al (2006) Analysis of expression of secreted phospholipases A2 in mouse tissues at protein and mRNA levels. Biochim Biophys Acta 1761:745–756PubMedGoogle Scholar
  74. 74.
    Surrel F, Jemel I, Boilard E et al (2009) Group X phospholipase A2 stimulates the proliferation of colon cancer cells by producing various lipid mediators. Mol Pharmacol 76:778–790PubMedGoogle Scholar
  75. 75.
    Hite RD, Seeds MC, Jacinto RB et al (1998) Hydrolysis of surfactant-associated phosphatidylcholine by mammalian secretory phospholipases A2. Am J Physiol 275:L740–L747PubMedGoogle Scholar
  76. 76.
    Pruzanski W, Lambeau L, Lazdunsky M et al (2005) Differential hydrolysis of molecular species of lipoprotein phosphatidylcholine by groups IIA, V and X secretory phospholipases A2. Biochim Biophys Acta 1736:38–50PubMedGoogle Scholar
  77. 77.
    Karabina SA, Brocheriou I, Le Naour G et al (2006) Atherogenic properties of LDL particles modified by human group X secreted phospholipase A2 on human endothelial cell function. FASEB J 20:2547–2549PubMedGoogle Scholar
  78. 78.
    Hallstrand TS, Chi EY, Singer AG et al (2007) Secreted phospholipase A2 group X overexpression in asthma and bronchial hyperresponsiveness. Am J Respir Crit Care Med 176:1072–1078PubMedGoogle Scholar
  79. 79.
    Henderson WR Jr, Chi EY, Bollinger JG et al (2007) Importance of group X-secreted phospholipase A2 in allergen-induced airway inflammation and remodeling in a mouse asthma model. J Exp Med 204:865–877PubMedGoogle Scholar
  80. 80.
    Giannattasio G, Fujioka D, Xing W et al (2010) Group V secretory phospholipase A2 reveals its role in house dust mite-induced allergic pulmonary inflammation by regulation of dendritic cell function. J Immunol 185:4430–4438PubMedGoogle Scholar
  81. 81.
    Munoz NM, Meliton AY, Meliton LN et al (2009) Secretory group V phospholipase A2 regulates acute lung injury and neutrophilic inflammation caused by LPS in mice. Am J Physiol Lung Cell Mol Physiol 296:L879–L887PubMedGoogle Scholar
  82. 82.
    Sato H, Kato R, Isogai Y et al (2008) Analyses of group III secreted phospholipase A2 transgenic mice reveal potential participation of this enzyme in plasma lipoprotein modification, macrophage foam cell formation, and atherosclerosis. J Biol Chem 283:33483–33497PubMedGoogle Scholar
  83. 83.
    Kimura-Matsumoto M, Ishikawa Y, Komiyama K et al (2008) Expression of secretory phospholipase A2s in human atherosclerosis development. Atherosclerosis 196:81–91PubMedGoogle Scholar
  84. 84.
    Masuda S, Murakami M, Matsumoto S et al (2004) Localization of various secretory phospholipase A2 enzymes in male reproductive organs. Biochim Biophys Acta 1686:61–76PubMedGoogle Scholar
  85. 85.
    Escoffier J, Jemel I, Tanemoto A et al (2010) Group X phospholipase A2 is released during sperm acrosome reaction and controls fertility outcome in mice. J Clin Invest 120:1415–1428PubMedGoogle Scholar
  86. 86.
    Gelb MH, Valentin E, Ghomashchi F et al (2000) Cloning and recombinant expression of a structurally novel human secreted phospholipase A2. J Biol Chem 275:39823–39826PubMedGoogle Scholar
  87. 87.
    Huhtinen HT, Gronroos JO, Gronroos JM et al (2006) Antibacterial effects of human group IIA and group XIIA phospholipase A2 against Helicobacter pylori in vitro. APMIS 114:127–130PubMedGoogle Scholar
  88. 88.
    Rouault M, Bollinger JG, Lazdunski M et al (2003) Novel mammalian group XII secreted phospholipase A2 lacking enzymatic activity. Biochemistry 42:11494–11503PubMedGoogle Scholar
  89. 89.
    Chabot S, Koumanov K, Lambeau G et al (2003) Inhibitory effects of surfactant protein A on surfactant phospholipid hydrolysis by secreted phospholipases A2. J Immunol 171:995–1000PubMedGoogle Scholar
  90. 90.
    Saegusa J, Akakura N, Wu CY et al (2008) Pro-inflammatory secretory phospholipase A2 type IIA binds to integrins alphavbeta3 and alpha4beta1 and induces proliferation of monocytic cells in an integrin-dependent manner. J Biol Chem 283:26107–26115PubMedGoogle Scholar
  91. 91.
    Cintra-Francischinelli M, Pizzo P, Angulo Y et al (2010) The C-terminal region of a Lys49 myotoxin mediates Ca2+ influx in C2C12 myotubes. Toxicon 55:590–596PubMedGoogle Scholar
  92. 92.
    Boilard E, Bourgoin SG, Bernatchez C et al (2003) Identification of an autoantigen on the surface of apoptotic human T cells as a new protein interacting with inflammatory group IIA phospholipase A2. Blood 102:2901–2909PubMedGoogle Scholar
  93. 93.
    Smart BP, Oslund RC, Walsh LA et al (2006) The first potent inhibitor of mammalian group X secreted phospholipase A2: elucidation of sites for enhanced binding. J Med Chem 49:2858–2860PubMedGoogle Scholar
  94. 94.
    Sato R, Yamaga S, Watanabe K et al (2010) Inhibition of secretory phospholipase A2 activity attenuates lipopolysaccharide-induced acute lung injury in a mouse model. Exp Lung Res 36:191–200PubMedGoogle Scholar
  95. 95.
    Fujioka D, Saito Y, Kobayashi T et al (2008) Reduction in myocardial ischemia/reperfusion injury in group X secretory phospholipase A2-deficient mice. Circulation 117:2977–2985PubMedGoogle Scholar
  96. 96.
    Bowton DL, Dmitrienko AA, Israel E et al (2005) Impact of a soluble phospholipase A2 inhibitor on inhaled allergen challenge in subjects with asthma. J Asthma 42:65–71PubMedGoogle Scholar
  97. 97.
    Zeiher BG, Steingrub J, Laterre PF et al (2005) LY315920NA/S–5920, a selective inhibitor of group IIA secretory phospholipase A2, fails to improve clinical outcome for patients with severe sepsis. Crit Care Med 33:1741–1748PubMedGoogle Scholar
  98. 98.
    Ghosh M, Tucker DE, Burchett SA et al (2006) Properties of the Group IV phospholipase A2 family. Prog Lipid Res 45:487–510PubMedGoogle Scholar
  99. 99.
    Leslie CC (2004) Regulation of arachidonic acid availability for eicosanoid production. Biochem Cell Biol 82:1–17PubMedGoogle Scholar
  100. 100.
    Leslie CC (2004) Regulation of the specific release of arachidonic acid by cytosolic phospholipase A2. Prostaglandins Leukot Essent Fatty Acids 70:373–376PubMedGoogle Scholar
  101. 101.
    Jimenez JL, Smith GR, Contreras-Moreira B et al (2003) Functional recycling of C2 domains throughout evolution: a comparative study of synaptotagmin, protein kinase C and phospholipase C by sequence, structural and modelling approaches. J Mol Biol 333:621–639PubMedGoogle Scholar
  102. 102.
    Hirabayashi T, Murayama T, Shimizu T (2004) Regulatory mechanism and physiological role of cytosolic phospholipase A2. Biol Pharm Bull 27:1168–1173PubMedGoogle Scholar
  103. 103.
    Pickard RT, Chiou XG, Strifler BA et al (1996) Identification of essential residues for the catalytic function of 85-kDa cytosolic phospholipase A2. Probing the role of histidine, aspartic acid, cysteine, and arginine. J Biol Chem 271:19225–19231PubMedGoogle Scholar
  104. 104.
    Dessen A (2000) Structure and mechanism of human cytosolic phospholipase A(2). Biochim Biophys Acta 1488:40–47PubMedGoogle Scholar
  105. 105.
    Ohto T, Uozumi N, Hirabayashi T et al (2005) Identification of novel cytosolic phospholipase A(2)s, murine cPLA(2){delta}, {epsilon}, and {zeta}, which form a gene cluster with cPLA(2){beta}. J Biol Chem 280:24576–24583PubMedGoogle Scholar
  106. 106.
    Ghosh M, Loper R, Ghomashchi F et al (2007) Function, activity, and membrane targeting of cytosolic phospholipase A(2)zeta in mouse lung fibroblasts. J Biol Chem 282:11676–11686PubMedGoogle Scholar
  107. 107.
    Ghomashchi F, Naika GS, Bollinger JG et al (2010) Interfacial kinetic and binding properties of mammalian group IVB phospholipase A2 (cPLA2beta) and comparison with the other cPLA2 isoforms. J Biol Chem 285:36100–36111PubMedGoogle Scholar
  108. 108.
    Haq S, Kilter H, Michael A et al (2003) Deletion of cytosolic phospholipase A2 promotes striated muscle growth. Nat Med 9:944–951PubMedGoogle Scholar
  109. 109.
    Nagase T, Uozumi N, Ishii S et al (2002) A pivotal role of cytosolic phospholipase A(2) in bleomycin-induced pulmonary fibrosis. Nat Med 8:480–484PubMedGoogle Scholar
  110. 110.
    Miyaura C, Inada M, Matsumoto C et al (2003) An essential role of cytosolic phospholipase A2alpha in prostaglandin E2-mediated bone resorption associated with inflammation. J Exp Med 197:1303–1310PubMedGoogle Scholar
  111. 111.
    Hegen M, Sun L, Uozumi N et al (2003) Cytosolic phospholipase A2alpha-deficient mice are resistant to collagen-induced arthritis. J Exp Med 197:1297–1302PubMedGoogle Scholar
  112. 112.
    Bonventre J (2004) Cytosolic phospholipase A2alpha reigns supreme in arthritis and bone resorption. Trends Immunol 25:116–119PubMedGoogle Scholar
  113. 113.
    Sanchez-Mejia RO, Newman JW, Toh S et al (2008) Phospholipase A2 reduction ameliorates cognitive deficits in a mouse model of Alzheimer’s disease. Nat Neurosci 11:1311–1318PubMedGoogle Scholar
  114. 114.
    Hartney JM, Coggins KG, Tilley SL et al (2006) Prostaglandin E2 protects lower airways against bronchoconstriction. Am J Physiol Lung Cell Mol Physiol 290:L105–L113PubMedGoogle Scholar
  115. 115.
    Francois H, Athirakul K, Howell D et al (2005) Prostacyclin protects against elevated blood pressure and cardiac fibrosis. Cell Metab 2:201–207PubMedGoogle Scholar
  116. 116.
    Ilsley JN, Nakanishi M, Flynn C et al (2005) Cytoplasmic phospholipase A2 deletion enhances colon tumorigenesis. Cancer Res 65:2636–2643PubMedGoogle Scholar
  117. 117.
    Meyer AM, Dwyer-Nield LD, Hurteau GJ et al (2004) Decreased lung tumorigenesis in mice genetically deficient in cytosolic phospholipase A2. Carcinogenesis 25:1517–1524PubMedGoogle Scholar
  118. 118.
    Downey P, Sapirstein A, O’Leary E et al (2001) Renal concentrating defect in mice lacking group IV cytosolic phospholipase A(2). Am J Physiol Renal Physiol 280:F607–F618PubMedGoogle Scholar
  119. 119.
    Wong DA, Kita Y, Uozumi N et al (2002) Discrete role for cytosolic phospholipase A(2)alpha in platelets: studies using single and double mutant mice of cytosolic and group IIA secretory phospholipase A(2). J Exp Med 196:349–357PubMedGoogle Scholar
  120. 120.
    Adler DH, Cogan JD, Phillips JA 3rd et al (2008) Inherited human cPLA(2alpha) deficiency is associated with impaired eicosanoid biosynthesis, small intestinal ulceration, and platelet dysfunction. J Clin Invest 118:2121–2131PubMedGoogle Scholar
  121. 121.
    Reed KA, Tucker DE, Aloulou A et al (2011) Functional Characterization of Mutations in Inherited Human cPLA(2) Deficiency. Biochemistry 50:1731–1738PubMedGoogle Scholar
  122. 122.
    Akiba S, Sato T (2004) Cellular function of calcium-independent phospholipase A2. Biol Pharm Bull 27:1174–1178PubMedGoogle Scholar
  123. 123.
    Balsinde J, Balboa MA (2005) Cellular regulation and proposed biological functions of group VIA calcium-independent phospholipase A2 in activated cells. Cell Signal 17:1052–1062PubMedGoogle Scholar
  124. 124.
    Lio YC, Dennis EA (1998) Interfacial activation, lysophospholipase and transacylase activity of group VI Ca2+-independent phospholipase A2. Biochim Biophys Acta 1392:320–332PubMedGoogle Scholar
  125. 125.
    Jenkins CM, Yan W, Mancuso DJ et al (2006) Highly selective hydrolysis of fatty acyl-CoAs by calcium-independent phospholipase A2beta. Enzyme autoacylation and acyl-CoA-mediated reversal of calmodulin inhibition of phospholipase A2 activity. J Biol Chem 281:15615–15624PubMedGoogle Scholar
  126. 126.
    Sharma J, Turk J, McHowat J (2010) Endothelial cell prostaglandin I(2) and platelet-activating factor production are markedly attenuated in the calcium-independent phospholipase A(2)beta knockout mouse. Biochemistry 49:5473–5481PubMedGoogle Scholar
  127. 127.
    Yan W, Jenkins CM, Han X et al (2005) The highly selective production of 2-arachidonoyl lysophosphatidylcholine catalyzed by purified calcium-independent phospholipase A2gamma: identification of a novel enzymatic mediator for the generation of a key branch point intermediate in eicosanoid signaling. J Biol Chem 280:26669–26679PubMedGoogle Scholar
  128. 128.
    Jenkins CM, Mancuso DJ, Yan W et al (2004) Identification, cloning, expression, and purification of three novel human calcium-independent phospholipase A2 family members possessing triacylglycerol lipase and acylglycerol transacylase activities. J Biol Chem 279:48968–48975PubMedGoogle Scholar
  129. 129.
    Ghosh M, Loper R, Gelb MH et al (2006) Identification of the expressed form of human cytosolic phospholipase A2beta (cPLA2beta): cPLA2beta3 is a novel variant localized to mitochondria and early endosomes. J Biol Chem 281:16615–16624PubMedGoogle Scholar
  130. 130.
    Wilensky RL, Macphee CH (2009) Lipoprotein-associated phospholipase A(2) and atherosclerosis. Curr Opin Lipidol 20:415–420PubMedGoogle Scholar
  131. 131.
    Packard CJ (2009) Lipoprotein-associated phospholipase A2 as a biomarker of coronary heart disease and a therapeutic target. Curr Opin Cardiol 24:358–363PubMedGoogle Scholar
  132. 132.
    Arai H (2002) Platelet-activating factor acetylhydrolase. Prostaglandins Other Lipid Mediat 68–69:83–94PubMedGoogle Scholar
  133. 133.
    Tjoelker LW, Wilder C, Eberhardt C et al (1995) Anti-inflammatory properties of a platelet-activating factor acetylhydrolase. Nature 374:549–553PubMedGoogle Scholar
  134. 134.
    Samanta U, Bahnson BJ (2008) Crystal structure of human plasma platelet-activating factor acetylhydrolase: structural implication to lipoprotein binding and catalysis. J Biol Chem 283:31617–31624PubMedGoogle Scholar
  135. 135.
    Stafforini DM, Tjoelker LW, McCormick SP et al (1999) Molecular basis of the interaction between plasma platelet-activating factor acetylhydrolase and low density lipoprotein. J Biol Chem 274:7018–7024PubMedGoogle Scholar
  136. 136.
    Prescott SM, Zimmerman GA, Stafforini DM et al (2000) Platelet-activating factor and related lipid mediators. Annu Rev Biochem 69:419–445PubMedGoogle Scholar
  137. 137.
    Tsimikas S, Tsironis LD, Tselepis AD (2007) New insights into the role of lipoprotein(a)-associated lipoprotein-associated phospholipase A2 in atherosclerosis and cardiovascular disease. Arterioscler Thromb Vasc Biol 27:2094–2099PubMedGoogle Scholar
  138. 138.
    Macphee CH, Nelson JJ, Zalewski A (2005) Lipoprotein-associated phospholipase A2 as a target of therapy. Curr Opin Lipidol 16:442–446PubMedGoogle Scholar
  139. 139.
    Wilensky RL, Shi Y, Mohler ER 3rd et al (2008) Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development. Nat Med 14:1059–1066PubMedGoogle Scholar
  140. 140.
    Serruys PW, Garcia-Garcia HM, Buszman P et al (2008) Effects of the direct lipoprotein-associated phospholipase A(2) inhibitor darapladib on human coronary atherosclerotic plaque. Circulation 118:1172–1182PubMedGoogle Scholar
  141. 141.
    Kono N, Inoue T, Yoshida Y et al (2008) Protection against oxidative stress-induced hepatic injury by intracellular type II platelet-activating factor acetylhydrolase by metabolism of oxidized phospholipids in vivo. J Biol Chem 283:1628–1636PubMedGoogle Scholar
  142. 142.
    Manya H, Aoki J, Watanabe M et al (1998) Switching of platelet-activating factor acetylhydrolase catalytic subunits in developing rat brain. J Biol Chem 273:18567–18572PubMedGoogle Scholar
  143. 143.
    Kitsiouli E, Nakos G, Lekka ME (2009) Phospholipase A2 subclasses in acute respiratory distress syndrome. Biochim Biophys Acta 1792:941–953PubMedGoogle Scholar
  144. 144.
    Kim TS, Sundaresh CS, Feinstein SI et al (1997) Identification of a human cDNA clone for lysosomal type Ca2+-independent phospholipase A2 and properties of the expressed protein. J Biol Chem 272:2542–2550PubMedGoogle Scholar
  145. 145.
    Chen JW, Dodia C, Feinstein SI et al (2000) 1-Cys peroxiredoxin, a bifunctional enzyme with glutathione peroxidase and phospholipase A2 activities. J Biol Chem 275:28421–28427PubMedGoogle Scholar
  146. 146.
    Bridges JP, Ikegami M, Brilli LL et al (2010) LPCAT1 regulates surfactant phospholipid synthesis and is required for transitioning to air breathing in mice. J Clin Invest 120:1736–1748PubMedGoogle Scholar
  147. 147.
    Hiraoka M, Abe A, Lu Y et al (2006) Lysosomal phospholipase A2 and phospholipidosis. Mol Cell Biol 26:6139–6148PubMedGoogle Scholar
  148. 148.
    Duncan RE, Sarkadi-Nagy E, Jaworski K et al (2008) Identification and functional characterization of adipose-specific phospholipase A2 (AdPLA). J Biol Chem 283:25428–25436PubMedGoogle Scholar
  149. 149.
    Sers C, Emmenegger U, Husmann K et al (1997) Growth-inhibitory activity and downregulation of the class II tumor-suppressor gene H-rev107 in tumor cell lines and experimental tumors. J Cell Biol 136:935–944PubMedGoogle Scholar
  150. 150.
    Uyama T, Morishita J, Jin XH et al (2009) The tumor suppressor gene H-Rev107 functions as a novel Ca2+-independent cytosolic phospholipase A1/2 of the thiol hydrolase type. J Lipid Res 50:685–693PubMedGoogle Scholar
  151. 151.
    Sanchez-Alavez M, Klein I, Brownell SE et al (2007) Night eating and obesity in the EP3R-deficient mouse. Proc Natl Acad Sci USA 104:3009–3014PubMedGoogle Scholar
  152. 152.
    Morgan CP, Insall R, Haynes L et al (2004) Identification of phospholipase B from Dictyostelium discoideum reveals a new lipase family present in mammals, flies and nematodes, but not yeast. Biochem J 382:441–449PubMedGoogle Scholar
  153. 153.
    Chen SC, Wright LC, Santangelo RT et al (1997) Identification of extracellular phospholipase B, lysophospholipase, and acyltransferase produced by Cryptococcus neoformans. Infect Immun 65:405–411PubMedGoogle Scholar
  154. 154.
    Lu T, Ito M, Tchoua U et al (2001) Identification of essential residues for catalysis of rat intestinal phospholipase B/lipase. Biochemistry 40:7133–7139PubMedGoogle Scholar
  155. 155.
    Ghannoum MA (1998) Extracellular phospholipases as universal virulence factor in pathogenic fungi. Nippon Ishinkin Gakkai Zasshi 39:55–59Google Scholar
  156. 156.
    Schwarzer N, Nost R, Seybold J et al (1998) Two distinct phospholipases C of Listeria monocytogenes induce ceramide generation, nuclear factor-kappa B activation, and E-selectin expression in human endothelial cells. J Immunol 161:3010–3018PubMedGoogle Scholar
  157. 157.
    Katan M (1998) Families of phosphoinositide-specific phospholipase C: structure and function. Biochim Biophys Acta 1436:5–17PubMedGoogle Scholar
  158. 158.
    Heinz DW, Essen LO, Williams RL (1998) Structural and mechanistic comparison of prokaryotic and eukaryotic phosphoinositide-specific phospholipases C. J Mol Biol 275:635–650PubMedGoogle Scholar
  159. 159.
    Iwasaki Y, Nishikawa S, Tsuneda M et al (2004) Detection of phospholipase D on solid materials. Anal Biochem 329:157–159PubMedGoogle Scholar
  160. 160.
    McDermott M, Wakelam MJ, Morris AJ (2004) Phospholipase D. Biochem Cell Biol 82:225–253PubMedGoogle Scholar
  161. 161.
    Leiros I, Secundo F, Zambonelli C et al (2000) The first crystal structure of a phospholipase D. Structure 8:655–667PubMedGoogle Scholar
  162. 162.
    Liscovitch M, Czarny M, Fiucci G et al (2000) Phospholipase D: molecular and cell biology of a novel gene family. Biochem J 345(Pt 3):401–415PubMedGoogle Scholar
  163. 163.
    McNamara PJ, Cuevas WA, Songer JG (1995) Toxic phospholipases D of Corynebacterium pseudotuberculosis. C. ulcerans and Arcanobacterium haemolyticum: cloning and sequence homology. Gene 156:113–118PubMedGoogle Scholar
  164. 164.
    Shimizu T, Ohto T, Kita Y (2006) Cytosolic phospholipase A2: biochemical properties and physiological roles. IUBMB Life 58:328–333PubMedGoogle Scholar
  165. 165.
    Clausen K (2001) Enzymatic oil-degumming by a novel microbial phospholipase. Eur J Lipid Sci Technol 103:333–340Google Scholar
  166. 166.
    MacRitchie F (1977) Flour lipids and their effects in baking. J Sci Food Agric 28:53–58Google Scholar
  167. 167.
    Dutilh CE, Groger W (1981) Improvement of product attributes of mayonnaise by enzymic hydrolysis of egg yolk with phospholipase A2. J Sci Food Agric 32:451–458Google Scholar
  168. 168.
    Daimer K, Kulozik U (2008) Impact of a treatment with phospholipase A2 on the physicochemical properties of Hen Egg yolk. J Agric Food Chem 56:4172–4180PubMedGoogle Scholar
  169. 169.
    Nebesny E, Rosicka J, Pierzgalski T (1998) Enzymatic hydrolysis of wheat starch into glucose. Starch - Stärke 50:337–341Google Scholar
  170. 170.
    Lilbæk HM, Broe ML, Høier E et al (2006) Improving the yield of mozzarella cheese by phospholipase treatment of milk. J Dairy Sci 89:4114–4125PubMedGoogle Scholar

Copyright information

© Springer Science+Business Media New York 2012

Authors and Affiliations

  • Ahmed Aloulou
    • 1
    Email author
  • Yassine Ben Ali
    • 2
  • Sofiane Bezzine
    • 1
    • 3
  • Youssef Gargouri
    • 3
  • Michael H. Gelb
    • 4
  1. 1.National School of Engineers of SfaxUniversity of SfaxSfaxTunisia
  2. 2.Laboratoire de Biochimie et de Génie Enzymatique des Lipases, ENISUniversity of SfaxSfaxTunisia
  3. 3.Laboratoire de Biochimie et de Génie Enzymatique des LipasesEcole Nationale d’Ingénieurs de SfaxSfaxTunisia
  4. 4.Departments of Chemistry and BiochemistryUniversity of WashingtonSeattleUSA

Personalised recommendations